Tratamiento con la administración intradiscal de plasma rico en plaquetas para dolor crónico discogénico cervical y lumbar

  1. Luis Miguel Torres Morera 1
  2. María Victoria García-Palacios 2
  3. Diego Benítez Pareja 2
  4. Ramón Eizaga Rebollar 2
  5. José Antonio López López 2
  6. Rogelio Sánchez de las Matas 3
  7. Enrique Calderón Seoane 3
  1. 1 Universidad de Cádiz

    Universidad de Cádiz

    Cádiz, España


  2. 2 Hospital Puerta del Mar
  3. 3 Hospital Clínico del Puerto Real
MPJ Multidisciplinary Pain Journal

ISSN: 2697-2263

Year of publication: 2021

Issue: 1

Type: Article

More publications in: MPJ Multidisciplinary Pain Journal


Introduction: Intervertebral disc degeneration (DIV) has been correlated with discogenic lumbar and cervical pain, is a serious health problem, as well as one of the leading causes of disability and represents an alarming health and socioeconomic problem. Platelet Rich Plasma (PRP) is a safe and effective therapeutic approach to musculoskeletal degenerative conditions and seems a clinically promising method on degenerate and injured discs. Methods: In this work we present our experience in the treatment of discogenic pain and evaluate changes in pain and function in 24 patients with discogenic cervical and lumbar pain following after epidural, paravertebral and intradiscal administration of PRP. Results: 24 patients (14 men and 10 women) have been treated. The initial Vas was 5.9 ± 0.7; 2 months of 2.8, ± 0.89 (p = 0.000); 6 months 1.4 ± 0.90 (p = 0.000) and 12 months of 2.1 ± 0.799 (p = 0.000). The initial ODI index was 43.20 ± 11.56; 2 months of 25.05 ± 7,783, (p = 0.100) of 21 ± 6,740; 6 months (p = 0.016) and 19.1 ± 7,498 at 12 months (p = 0.000). Conclusion: Our results are encouraging at 2, 6 and 12 months, using strict categorical diagnostic criteria, for the use of epidural and intradiscal PRP as a treatment for discogenic cervical and lumbar pain as it significantly decreased physical pain and disability Randomized placebo-controlled trials are needed to further evaluate the effectiveness of this treatment.

Bibliographic References

  • Wang Y, Videman T, Battie MC. ISSLS prize winner: lumbar vertebral endplate lesions: associations with disc degeneration and back pain history. Spine (Phila Pa 1976). 2012;37(17):1490-6. DOI: 10.1097/BRS.0b013e3182608ac4.
  • Olmarker K. Back pain and disc degeneration: are they really linked? In: The Intervertebral Disc. Vienna, Austria: Springer; 2014. p. 261-75.
  • Peng B, Pang X, Wu Y, Zhao C, Song X. A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Pain 2010;149(1):124-9. DOI: 10.1016/j.pain.2010.01.021.
  • Torres LM, Terrero MJ, Vidal M, Aragón A, Martínez J. Discólisis con O3 intradiscal en el tratamiento de la ciática por hernia discal. Seguimiento de 100 pacientes en 24 meses. Rev Soc Esp Dolor. 2009;16(3):147-52. DOI: 10.1016/S1134-8046(09)71006-7.
  • Bellini M, Romano D, Arrigucci U, Bracco S, Cerase A. Percutaneous treatment of lumbar and cervical intervertebral disc herniations with radiopaque gelified ethanol (RGE): clinical and morphostructural changes in our experience [Internet]. JVIR: Disponible en: DOI: 10.1016/j.jvir.2013.01.486.
  • Migliorini F, Rath B, Tingart M, Baroncini A, Quack V, Eschweiler J. Autogenic mesenchymal stem cells for intervertebral disc regeneration. Int Orthop. 2019;43(4):1027-36. DOI: 10.1007/s00264-018-4218-y.
  • Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016;40(6):1321-8. DOI: 10.1007/s00264-016-3178-3.
  • Padilla S, Sanchez M, Orive G, Anitua E. Human-based biological and biomimetic autologous therapies for musculoskeletal tissue regeneration. Trends Biotechnol. 2017;35(3):192-202. DOI: 10.1016/j.tibtech.2016.09.008.
  • Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R, et al. Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther. 2012:14(6):R241. DOI: 10.1186/ar4084.
  • Akeda K, Yamada J, Linn ET, Sudo A, Masuda K. Platelet-rich plasma in the management of chronic low back pain: a critical review. J Pain Res. 2019;12:753-67. DOI: 10.2147/JPR.S153085.
  • Gullung GB, Woodall JW, Tucci MA, James J, Black DA, McGuire RA. Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J 2011;2(4):13-18. DOI: 10.1055/s-0031-1274752.
  • Chou D, Samartzis D, Bellabarba C, Patel A, Luk KDK, Schenk Kisser JM, et al. Degenerative magnetic resonance imaging changes in patients with chronic low back pain: a systematic review. Spine. 2011;36 (Suppl. 21):S43-S53. DOI: 10.1097/BRS.0b013e31822ef700.
  • Urits I, Viswanath O, Galasso AC, Sottosani ER, Mahan KM, Aiudi CM, et al. Platelet-Rich Plasma for the Treatment of Low Back Pain: a Comprehensive Review. Curr Pain Headache Rep. 2019;23(7):52. DOI: 10.1007/s11916-019-0797-6. DOI: 10.1007/s11916-019-0797-6.
  • Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br. 2007;89(3):417-20. DOI: 10.1302/0301-620X.89B3.18491.
  • Fabbro MD, Bortolin M, Taschieri S, Ceci C, Weinstein RL. Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets. 2016;27(4):276-85. DOI: 10.3109/09537104.2015.1116686.
  • Lutz GE. Increased Nuclear T2 Signal Intensity and Improved Function and Pain in a Patient One Year After an Intradiscal Platelet-Rich Plasma Injection. Pain Med. 2017;18(6):1197-9. DOI: 10.1093/pm/pnw299.
  • Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21(12):739-48. DOI: 10.5435/00124635-201312000-00004.
  • Barile A, La Marra A, Arrigoni F, Mariani S, Zugaro L, Splendiani A, et al. Anaesthetics, steroids and platelet-rich plasma (PRP) in ultrasound- guided musculoskeletal procedures. Br J Radiol. 2016;89(1065):20150355. DOI: 10.1259/bjr.20150355.
  • Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018;4(1):115-22. DOI: 10.21037/jss.2018.03.04.
  • Phan K, Mobbs RJ. Systematic reviews and meta-analyses in spine surgery, neurosurgery and orthopedics: guidelines for the surgeon scientist. J Spine Surg 2015;1(1):19-27.
  • Navani A, Manchikanti L, Albers SL, Latchaw RE, Sanapati J, Kaye AD, et al. Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2019;22(1S): S1-S74. DOI: 10.36076/ppj/2019.22.s1.